1. Home
  2. XLO vs KSCP Comparison

XLO vs KSCP Comparison

Compare XLO & KSCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • KSCP
  • Stock Information
  • Founded
  • XLO 2016
  • KSCP 2013
  • Country
  • XLO United States
  • KSCP United States
  • Employees
  • XLO N/A
  • KSCP N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • KSCP Telecommunications Equipment
  • Sector
  • XLO Health Care
  • KSCP Telecommunications
  • Exchange
  • XLO Nasdaq
  • KSCP Nasdaq
  • Market Cap
  • XLO 42.2M
  • KSCP 35.9M
  • IPO Year
  • XLO 2021
  • KSCP 2022
  • Fundamental
  • Price
  • XLO $0.74
  • KSCP $7.36
  • Analyst Decision
  • XLO Buy
  • KSCP Strong Buy
  • Analyst Count
  • XLO 1
  • KSCP 3
  • Target Price
  • XLO $4.00
  • KSCP $15.67
  • AVG Volume (30 Days)
  • XLO 416.8K
  • KSCP 408.7K
  • Earning Date
  • XLO 08-07-2025
  • KSCP 08-13-2025
  • Dividend Yield
  • XLO N/A
  • KSCP N/A
  • EPS Growth
  • XLO N/A
  • KSCP N/A
  • EPS
  • XLO N/A
  • KSCP N/A
  • Revenue
  • XLO $9,274,000.00
  • KSCP $11,468,000.00
  • Revenue This Year
  • XLO $300.08
  • KSCP $16.17
  • Revenue Next Year
  • XLO $1.87
  • KSCP $39.02
  • P/E Ratio
  • XLO N/A
  • KSCP N/A
  • Revenue Growth
  • XLO N/A
  • KSCP N/A
  • 52 Week Low
  • XLO $0.62
  • KSCP $2.45
  • 52 Week High
  • XLO $1.70
  • KSCP $28.57
  • Technical
  • Relative Strength Index (RSI)
  • XLO 55.04
  • KSCP 69.42
  • Support Level
  • XLO $0.67
  • KSCP $6.33
  • Resistance Level
  • XLO $0.70
  • KSCP $7.32
  • Average True Range (ATR)
  • XLO 0.03
  • KSCP 0.49
  • MACD
  • XLO 0.01
  • KSCP 0.25
  • Stochastic Oscillator
  • XLO 98.84
  • KSCP 81.65

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

Share on Social Networks: